Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Greater China Junior Stocks -- Ignore unavailable to you. Want to Upgrade?

To: diddlysquatz who wrote (1633)	4/20/2008 8:34:06 AM
From: InvestingInChina	Read Replies (1) \| Respond to of 1992

I'm seeing that as well. Many have been beaten down 50-75% from highs last year, as though they were going out of business, have been reporting excellent results for FY 207 and/or Q1 '08. I think the bottom has been placed in many of the China micros, and as China's economy continues to grow at 8-11%/year as the US/Europe slow more and more, the $$$ will continue to flow into them. Who can argue with a company like LTUS.OB (Lotus Pharmaceuticals) that has .40 cash/share, growing income at over 100% yoy 3 years in a row, has 14 new drugs in late stage development, (3 to be released this year) made .26/share for 2007, and closed Friday at only .99 (yes, ninety-nine cents!) ? That's just a ridiculous valuation (PE multiple of about 3 on ttm income) if you ask me- especially when conf. call and forward guidance suggests their past growth rate will continue into 2008-2009.